COVID-19 Pandemic and Mental Health: Prevalence and Correlates of New-Onset Obsessive-Compulsive Symptoms in a Canadian Province

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2020 Sep 29

PMID 32987764

Citations 58

Authors

Adam Abba-Aji

Daniel Li

Marianne Hrabok

Reham Shalaby

April Gusnowski

Wesley Vuong

Shireen Surood

Nnamdi Nkire

Xin-Min Li

Andrew J Greenshaw

Vincent I O Agyapong

Affiliations

Soon will be listed here.

Abstract

: This cross-sectional online survey investigates the prevalence of obsessive-compulsive disorder (OCD) symptoms at an early stage of the COVID-19 pandemic in Canada. : OCD symptoms, moderate/high stress, likely generalized anxiety disorder (GAD) and likely major depressive disorder (MDD) were assessed with the Brief Obsessive-Compulsive Scale (BOCS), Perceived Stress Scale (PSS), Generalized Anxiety Disorder 7-item (GAD-7) scale, and Patient Health Questionnaire-9 (PHQ-9) scale, respectively. : Out of 32,805 individuals subscribed to Text4Hope, 6041 completed an online survey; the response rate was 18.4%. Overall, 60.3% of respondents reported onset of OCD symptoms and 53.8% had compulsions to wash hands during the COVID-19 pandemic. Respondents who showed OCD symptoms only since the start of COVID-19 were significantly more likely to have moderate/high stress (z = 6.4, < 0.001), likely GAD (z = 6.0, < 0.001), and likely MDD (z = 2.7, < 0.01). Similarly, respondents who engaged in compulsive hand washing were significantly more likely to have moderate/high stress (z = 4.6, < 0.001) and likely GAD (z = 4.6 < 0.001), but not likely MDD (z = 1.4, = 0.16). : The prevalence of OCD symptoms increased during the COVID-19 pandemic, at a rate significantly higher than pre-pandemic rates reported for the sample population. Presenting with OCD symptoms increased the likelihood of presenting with elevated stress, likely GAD, and likely MDD.

Citing Articles

Obsessive-Compulsive Symptoms in the General Population Under Stressful Conditions: Lessons Learned from the COVID-19 Pandemic.

Pellegrini L, Albert U, Carmassi C, Carra G, Cirulli F, DellOsso B Brain Sci. 2025; 14(12.

PMID: 39766479 PMC: 11674853. DOI: 10.3390/brainsci14121280.

Obsessive-compulsive symptom trajectories from pregnancy through the postpartum: examining longitudinal course and risk factors during the COVID-19 pandemic.

Levinson A, Preis H, Lobel M, Philippopoulos A, Law K, Mahaffey B Arch Womens Ment Health. 2024; .

PMID: 39419882 DOI: 10.1007/s00737-024-01524-3.

Too much of a good thing? Hand hygiene and the long-term course of contamination-related obsessive-compulsive symptoms.

Jelinek L, Goritz A, Miegel F, Schuurmans L, Moritz S, Yassari A Front Psychol. 2024; 15:1279639.

PMID: 38524298 PMC: 10959097. DOI: 10.3389/fpsyg.2024.1279639.

Comparison of healthcare workers and non-healthcare workers in terms of obsessive-compulsive and depressive symptoms during COVID-19 pandemic: a longitudinal case-controlled study.

Uyar B, Donmezdil S Front Public Health. 2023; 11:1283317.

PMID: 38152663 PMC: 10751325. DOI: 10.3389/fpubh.2023.1283317.

Disgust-reduction evaluative conditioning (DREC) and brain stimulation in patients with contamination-based obsessive-compulsive disorder: a protocol for a randomized control trial.

Al Mohaddesin F, Moghimi A, Fadardi J Trials. 2023; 24(1):750.

PMID: 38001473 PMC: 10675853. DOI: 10.1186/s13063-023-07791-2.

References

Fontenelle L, Mendlowicz M, Versiani M . The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30(3):327-37. DOI: 10.1016/j.pnpbp.2005.11.001. View

Grad F . Communicable disease and mental health: restrictions of the person. Am J Law Med. 1986; 12(3-4):381-403. View

Brakoulias V, Starcevic V, Belloch A, Brown C, Ferrao Y, Fontenelle L . Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration. Compr Psychiatry. 2017; 76:79-86. DOI: 10.1016/j.comppsych.2017.04.002. View

Agyapong V, Mrklas K, Juhas M, Omeje J, Ohinmaa A, Dursun S . Cross-sectional survey evaluating Text4Mood: mobile health program to reduce psychological treatment gap in mental healthcare in Alberta through daily supportive text messages. BMC Psychiatry. 2016; 16(1):378. PMC: 5100254. DOI: 10.1186/s12888-016-1104-2. View

Armstrong T, Zald D, Olatunji B . Attentional control in OCD and GAD: specificity and associations with core cognitive symptoms. Behav Res Ther. 2011; 49(11):756-62. PMC: 3266065. DOI: 10.1016/j.brat.2011.08.003. View

Agyapong V, Milnes J, McLoughlin D, Farren C . Perception of patients with alcohol use disorder and comorbid depression about the usefulness of supportive text messages. Technol Health Care. 2013; 21(1):31-9. DOI: 10.3233/THC-120707. View

Subramaniam M, Abdin E, Vaingankar J, Chong S . Obsessive--compulsive disorder: prevalence, correlates, help-seeking and quality of life in a multiracial Asian population. Soc Psychiatry Psychiatr Epidemiol. 2012; 47(12):2035-43. DOI: 10.1007/s00127-012-0507-8. View

Agyapong V . Coronavirus Disease 2019 Pandemic: Health System and Community Response to a Text Message (Text4Hope) Program Supporting Mental Health in Alberta. Disaster Med Public Health Prep. 2020; 14(5):e5-e6. PMC: 7198462. DOI: 10.1017/dmp.2020.114. View

Li S, Wang Y, Xue J, Zhao N, Zhu T . The Impact of COVID-19 Epidemic Declaration on Psychological Consequences: A Study on Active Weibo Users. Int J Environ Res Public Health. 2020; 17(6). PMC: 7143846. DOI: 10.3390/ijerph17062032. View

10.

Fullana M, Mataix-Cols D, Caspi A, Harrington H, Grisham J, Moffitt T . Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry. 2009; 166(3):329-36. PMC: 3818089. DOI: 10.1176/appi.ajp.2008.08071006. View

11.

Rosso G, Albert U, Asinari G, Bogetto F, Maina G . Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions. Psychiatry Res. 2012; 197(3):259-64. DOI: 10.1016/j.psychres.2011.10.005. View

12.

Bobes J, Gonzalez M, Bascaran M, Arango C, Saiz P, Bousono M . Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry. 2001; 16(4):239-45. DOI: 10.1016/s0924-9338(01)00571-5. View

13.

Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N . Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open. 2020; 3(3):e203976. PMC: 7090843. DOI: 10.1001/jamanetworkopen.2020.3976. View

14.

Ruscio A, Stein D, Chiu W, Kessler R . The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2008; 15(1):53-63. PMC: 2797569. DOI: 10.1038/mp.2008.94. View

15.

Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

16.

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

17.

Bejerot S, Edman G, Anckarsater H, Berglund G, Gillberg C, Hofvander B . The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders. Nord J Psychiatry. 2014; 68(8):549-59. PMC: 4221004. DOI: 10.3109/08039488.2014.884631. View

18.

Lochner C, Fineberg N, Zohar J, Van Ameringen M, Juven-Wetzler A, Altamura A . Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Compr Psychiatry. 2014; 55(7):1513-9. DOI: 10.1016/j.comppsych.2014.05.020. View

19.

Cromer K, Schmidt N, Murphy D . An investigation of traumatic life events and obsessive-compulsive disorder. Behav Res Ther. 2006; 45(7):1683-91. DOI: 10.1016/j.brat.2006.08.018. View

20.

Fineberg N, DellOsso B, Albert U, Maina G, Geller D, Carmi L . Early intervention for obsessive compulsive disorder: An expert consensus statement. Eur Neuropsychopharmacol. 2019; 29(4):549-565. DOI: 10.1016/j.euroneuro.2019.02.002. View